Clearance Summary
LATERALIZED INTERGRAL POROUS PRIMARY FEMORAL COMPONENT received FDA 510(k) clearance under submission number K984296, sponsored by Biomet, Inc.. The device was reviewed via the Traditional premarket notification pathway and assigned to the Orthopedic review panel. The statutory decision date of record is 1999-02-18.
- Submission: K984296
- Applicant / Sponsor: Biomet, Inc.
- Clearance pathway: Traditional
- Review panel: Orthopedic
- Device class: Class II
- Regulation citation: 21 CFR 888.3358
- Decision date: 1999-02-18
Classification & Regulation
This clearance is catalogued under FDA product code LPH and 21 CFR 888.3358, within the Orthopedic review panel as a Class II device.